Coripharma

Coripharma is a private, revenue-generating pharmaceutical services company founded in 2003 and headquartered in Reykjavik, Iceland. It has carved a niche in the generic drug market by focusing on complex, high-barrier-to-entry small molecule products, leveraging specialized development and manufacturing expertise. The company's unique value proposition combines technical proficiency with a fully renewable-energy-powered production facility, targeting European out-licensing partners. It operates as a service provider and product developer for the generic pharmaceutical industry.

Specialized expertise in formulation development and process engineering for complex generic small molecules (solid oral dosage), combined with a manufacturing facility powered entirely by renewable geothermal and hydropower energy.

Coripharma competes with other specialized generic development companies and CDMOs that focus on complex products. Its primary differentiation is its integrated service model (development through manufacturing) from a single, sustainably-powered site in Iceland, which contrasts with larger, multi-site generic manufacturers and CDMOs that may not offer the same niche focus or environmental profile.